🇧🇪 Belgium Country × Condition
prostate cancer Clinical Trials in Belgium
Active clinical trials for prostate cancer with research sites in Belgium. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 1, Phase 2, Phase 4 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇧🇪 Belgium
Active Trials in Belgium (4)
NCT05413850 Phase 1, Phase 2
Recruiting
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Enrollment
82 pts
Country
🇧🇪 Belgium
Blue Earth Therapeutics Ltd
View Trial → NCT05344235
Recruiting
Observational Study on Extreme Hypofractionation for Localized Prostate Cancer
Enrollment
246 pts
Country
🇧🇪 Belgium
Universitaire Ziekenhuizen KU Leuve...
View Trial → NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Enrollment
700 pts
Country
🇧🇪 Belgium
Novartis Pharmaceuticals
View Trial → NCT04075305
Recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Enrollment
8,000 pts
Country
🇧🇪 Belgium
UMC Utrecht
View Trial → Frequently Asked Questions
How many prostate cancer clinical trials are active in Belgium?
There are currently 4 active clinical trials for prostate cancer with sites in Belgium, of which 4 are actively recruiting patients.
How can I join a prostate cancer clinical trial in Belgium?
To join a prostate cancer clinical trial in Belgium, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Belgium directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are prostate cancer trials in Belgium?
Active prostate cancer trials in Belgium span Phase 1, Phase 2, Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology